MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
3.100
+0.060 (1.97%)
Oct 19, 2026, 3:43 PM EDT - Market open
MannKind Market Cap
MannKind has a market cap or net worth of $996.78 million as of October 19, 2026. It is the 10,233rd most valuable company in the world and the 2,245th biggest in the United States. Its market cap has decreased by 40.61% in one year.
Market Cap
996.78M
Enterprise Value
1.32B
1-Year Change
-40.61%
Global Rank
Country Rank
#2,245 United States
Category
ChartMarket Cap Chart
Since July 28, 2004, MannKind's market cap has increased from $445.50M to $996.78M, an increase of 123.74%. That is a compound annual growth rate of 3.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 996.78M | -42.75% |
| Dec 31, 2025 | 1.74B | -1.82% |
| Dec 31, 2024 | 1.77B | 80.71% |
| Dec 29, 2023 | 981.30M | -29.25% |
| Dec 30, 2022 | 1.39B | 26.32% |
| Dec 31, 2021 | 1.10B | 50.82% |
| Dec 31, 2020 | 728.00M | 173.38% |
| Dec 31, 2019 | 266.30M | 57.39% |
| Dec 31, 2018 | 169.20M | -37.75% |
| Dec 29, 2017 | 271.80M | -10.74% |
| Dec 30, 2016 | 304.50M | -48.72% |
| Dec 31, 2015 | 593.80M | -71.93% |
| Dec 31, 2014 | 2.12B | 13.87% |
| Dec 31, 2013 | 1.86B | 227.29% |
| Dec 31, 2012 | 567.70M | 72.92% |
| Dec 30, 2011 | 328.30M | -67.35% |
| Dec 31, 2010 | 1.01B | 1.76% |
| Dec 31, 2009 | 988.20M | 183.23% |
| Dec 31, 2008 | 348.90M | -56.57% |
| Dec 31, 2007 | 803.30M | -2.49% |
| Dec 29, 2006 | 823.80M | 45.65% |
| Dec 30, 2005 | 565.60M | 9.46% |
| Dec 31, 2004 | 516.70M | 15.98% |
| Jul 28, 2004 | 445.50M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.09B |
| Vor Biopharma | 1.07B |
| Verastem | 1.05B |
| Avalyn Pharma | 1.05B |
| Replimune Group | 1.02B |
| Janux Therapeutics | 1.01B |
| Seaport Therapeutics | 954.45M |
| Latigo Biotherapeutics | 928.19M |